GlassScriptPhysician profile
Michael J Gibbons
NPI 1407857311
$3,947.66
in general payments reported to CMS, 2019-2025
16 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $188 · 2021: $261 · 2022: $1,744 · 2023: $642 · 2024: $444 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,557.68 | 2022 | |
| Zimmer Biomet Holdings, INC. | $964.92 | 2019-2024 | Persona, Osseoti Reconstructive System, Juggerstitch |
| Davol INC. | $338.25 | 2023-2025 | Arista, Arista Ah Flexitip |
| Prism Medical | $247.60 | 2024 | |
| Depuy Synthes Sales INC. | $193.07 | 2019-2024 | Monovisc |
| Ferring Pharmaceuticals INC. | $184.84 | 2019-2025 | Euflexxa |
| Wardlow Enterprises | $146.03 | 2022 | |
| Ethicon US, LLC | $108.74 | 2023 | Ethicon, Vistaseal |
| Stryker Corporation | $63.71 | 2019 | |
| Orthofix Medical, INC. | $28.50 | 2023 | Physio-Stim, Spinal-Stim |
| Kowa Pharmaceuticals America, INC. | $27.71 | 2022 | |
| Bioventus LLC | $26.08 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $19.70 | 2025 | |
| Amgen INC. | $15.06 | 2024 | Evenity |
| Pacira Pharmaceuticals Incorporated | $12.97 | 2023 | Zilretta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gibbons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.